Guaifenesin and Pseudoephedrine HCl
NDC 58602-833, Guaifenesin and Pseudoephedrine HCl, tablet, extended release, from Aurohealth LLC.
- Product NDC
- 58602-833
- Status
- Listed
- Labeler
- Aurohealth LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA213203
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58602-833 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN600 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE60 mg/1
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58602-833-12 | 58602083312 | 1 BLISTER PACK in 1 CARTON (58602-833-12) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
| 58602-833-17 | 58602083317 | 2 BLISTER PACK in 1 CARTON (58602-833-17) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58602-833 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58602-833 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58602-833. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.